Global reach ZRT Laboratory has a broad footprint with customers in all 50 states and 90 countries, including collaborations with major research entities like the CDC and NIH. This suggests potential for partnerships, distribution, and international expansion opportunities for new testing panels or white-label services.

Hormone testing leadership As a recognized leader in saliva and dried blood spot testing and the developer of dried urine testing for hormones, ZRT holds strong domain authority in endocrine diagnostics. This positions them as a potential co-development partner for advanced hormone, neurotransmitter, and element panels or for expanding to adjacent biomarker tests.

Diverse test portfolio With a history of launching Fertility Profile, LCMS Saliva Steroid Profile, Rare Elements Profile, and COVID-19 antibody tests, ZRT demonstrates agility in expanding offerings. This indicates opportunities to cross-sell or co-market new assay developments, kits for athletes, and niche biomarker testing to expand client bases.

Healthcare tech usage ZRT employs a digital toolkit including analytics and web technologies, suggesting receptiveness to client-facing digital solutions, data integration, and report automation partnerships. There is potential for selling data workflows, API integrations, or telehealth-enabled reporting enhancements.

Financial footing With estimated revenue in the mid-range of tens of millions and a focused niche presence, ZRT is a mid-sized specialty lab with growth potential. This creates opportunities for scalable B2B collaborations, regional sales growth, and value-driven partnerships with hospitals, clinics, and research teams.